title: Cyclic AMP and free fatty acids in the longer-term regulation of pyruvate dehydrogenase kinase in rat soleus muscle.
abstract: Starvation increased pyruvate dehydrogenase (PDH) kinase activity in extracts of freshly excised rat soleus 2.2-fold (from 0.6 min-1 in fed rats to 1.31 min-1 in 48-h-starved rats). In fed rats, activities were unchanged following 24 h of culture in medium 199, but increased 2.1-fold on 24 h of culture with 50 microM dibutyryl cAMP plus 1 mM n-octanoate and 1.6-1.7-fold with either agent alone. Approx. 70% of the increase in PDH kinase induced by starvation was lost following 24 h of culture in medium 199; the loss was prevented by 50 microM dibutyryl cAMP plus 1 mM n-octanoate. cAMP concentrations in fresh soleus muscle were 1 nmol/g (fed rats) and 1.6 nmol/g (starved rats). After 20-60 min of culture the fed-starved difference disappeared and [cAMP] fell to 0.4 nmol/g. Calcitonin-gene-related peptide (CGRP) increased cAMP 3-fold; the increase was maintained throughout 24 h of culture, but was readily reversed at 30 min or 24 h of culture by 60-min incubation with CGRP-free medium. Starvation of the rat (48 h) had no effect on the sensitivity of soleus towards the [cAMP]-increasing effect of CGRP. It is concluded that culture may reverse effects of starvation on PDH kinase activity by lowering cAMP and by removal from the in vivo effects of circulating free fatty acids; and that starvation and CGRP had no detectable long-term effects on the cAMP system in soleus muscle.
authors.affiliation: Nuffield Department of Clinical Biochemistry, University of Oxford, John Radcliffe Hospital, UK.
authors.forename: P B
authors.initials: PB
authors.lastname: Stace
authors.forename: H R
authors.initials: HR
authors.lastname: Fatania
authors.forename: A
authors.initials: A
authors.lastname: Jackson
authors.forename: A L
authors.initials: AL
authors.lastname: Kerbey
authors.forename: P J
authors.initials: PJ
authors.lastname: Randle
mesh_terms: D000243:Adenosine Deaminase / Q000494:pharmacology; D000682:Amyloid / Q000494:pharmacology; D000818:Animals; D003994:Bucladesine / Q000494:pharmacology*; D015740:Calcitonin Gene-Related Peptide / Q000494:pharmacology; D002210:Caprylates / Q000494:pharmacology; D002950:Citrate (si)-Synthase / Q000378:metabolism; D005230:Fatty Acids, Nonesterified / Q000494:pharmacology*; D066298:In Vitro Techniques; D007328:Insulin / Q000494:pharmacology; D058228:Islet Amyloid Polypeptide; D009132:Muscles / Q000187:drug effects* / Q000201:enzymology; D011494:Protein Kinases / Q000302:isolation & purification / Q000378:metabolism*; D017346:Protein Serine-Threonine Kinases; D000081382:Pyruvate Dehydrogenase Acetyl-Transferring Kinase; D051381:Rats; D013217:Starvation / Q000201:enzymology; D013806:Theophylline / Q000031:analogs & derivatives / Q000494:pharmacology; D014284:Triiodothyronine / Q000494:pharmacology
chemical_list: D000682:Amyloid; D002210:Caprylates; D005230:Fatty Acids, Nonesterified; D007328:Insulin; D058228:Islet Amyloid Polypeptide; D000081382:Pyruvate Dehydrogenase Acetyl-Transferring Kinase; D014284:Triiodothyronine; D003994:Bucladesine; D013806:Theophylline; C028322:8-phenyltheophylline; D002950:Citrate (si)-Synthase; D011494:Protein Kinases; D017346:Protein Serine-Threonine Kinases; D000243:Adenosine Deaminase; D015740:Calcitonin Gene-Related Peptide; C031492:octanoic acid